Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Group of people standing outside Wolfson College for a posed photo.

The European Magnetic Resonance Imaging in MS group (MAGNIMS) consists of nine different centres, collaborating on research and expert guidelines in the field. 

Our Neuromyelitis Optica and Multiple Sclerosis teams hosted a very successful 37th meeting of the MAGNIMS group at Wolfson College Oxford in May 2022, which marked 20 years of this collaboration. Sponsorship from UCB, Roche and Alexion made it possible.

The workshop topic was 'Identifying imaging features of MOG Antibody Disease (MOGAD) and differentiating it from MS : towards producing MOGAD imaging criteria'. This fits in with Oxford's highly specialised expertise in MOGAD and Neuromyelitis Optica. Experts in pathology and neuroimmunology as well as imaging participated, with speakers from Europe and the US. A review publication from the workshop is now planned.

The meeting was fully subscribed with 80 in-person participants and 30 people joining online. Ruth Geraldes and Silvia Messina provided a punting lesson for delegates. A celebratory cake included a model brain, although the two pathologists were not impressed!  

Similar stories

New study shows clinical symptoms for Alzheimer’s can be predicted in preclinical models

Establishing preclinical models of Alzheimer’s that reflect in-life clinical symptoms of each individual is a critically important goal, yet so far it has not been fully realised. A new collaborative study from the University of Oxford has demonstrated that clinical vulnerability to an abnormally abundant protein in Alzheimer’s brain is in fact reflected in individual patient induced pluripotent stem cell-derived cortical neurons.

New insights gained into how the brain encodes information about the world

Scientists have developed a new way to test the theory that active neurons can change what they signal in the world, rather than keeping a stable correspondence to things (such as a features of an object, or ideas).

Oxford and Quinnipiac researchers discuss integrated clinical care, education, and research in multiple sclerosis

Mount Sinai Rehabilitation Hospital's Mandell Center for Multiple Sclerosis Care and Neuroscience Research welcomed University of Oxford partners in September. Stakeholders from University of Oxford and Quinnipiac University met to discuss ongoing research and future opportunities to develop a Mandell MS Center concept of care in the UK.

Repurposed drug could help patients with motor neuron disease

A drug typically used to treat enlarged prostates and high blood pressure has shown promise as a potential new therapy for motor neuron disease (MND), according to a new study.

Finding out more about Parkinson’s by monitoring symptoms at home

Professor Chrystalina Antoniades explains how the COVID pandemic accelerated an innovation in one research project into Parkinson's Disease.